YorkBridge Wealth Partners’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-1,730
Closed -$160K 773
2019
Q2
$160K Hold
1,730
0.07% 212
2019
Q1
$163K Sell
1,730
-1,016
-37% -$88.9K 0.08% 194
2018
Q4
$176K Hold
2,746
0.09% 160
2018
Q3
$247K Sell
2,746
-35
-1% -$3.09K 0.11% 148
2018
Q2
$221K Sell
2,781
-586
-17% -$48.7K 0.1% 166
2018
Q1
$302K Sell
3,367
-124
-4% -$11.9K 0.14% 144
2017
Q4
$327K Sell
3,491
-8,611
-71% -$972K 0.16% 134
2017
Q3
$1.76M Sell
12,102
-296
-2% -$40.3K 0.92% 25
2017
Q2
$1.61M Buy
12,398
+483
+4% +$59.2K 0.86% 26
2017
Q1
$1.48M Buy
11,915
+2,574
+28% +$308K 0.77% 31
2016
Q4
$1.13M Buy
+9,341
New +$1.04M 0.67% 41

Other funds holding CELG

YorkBridge Wealth Partners's CELG Position: Q3 2019 in Review

YorkBridge Wealth Partners sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 1,730 shares — an estimated $160K sold.

YorkBridge Wealth Partners first reported a position in CELG in Q4 2016 and held it in 11 quarters. The position peaked at $1.76M in Q3 2017. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • YorkBridge Wealth Partners reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
  • YorkBridge Wealth Partners sold 1,730 Celgene Corp shares in Q3 2019, an estimated $160K.
  • YorkBridge Wealth Partners first reported a position in Celgene Corp in Q4 2016 and held it in 11 quarters.
  • YorkBridge Wealth Partners's Celgene Corp position peaked at $1.76M in Q3 2017.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on YorkBridge Wealth Partners's 13F filing for Q3 2019, filed 21 Oct 2019.